Archive | guidelines RSS feed for this section

Fraud in Academic Publishing: Researchers Under Cyber-Attacks

Day by day, researchers receive new suspicious e-mails in their inboxes. Many of them do not have sufficient information about these types of e-mails, and may become victims of cyber-attacks. In this short communication, we review current cyber threats in academic publishing and try to present general guidelines for authors. Nowadays, researchers often receive suspicious […]

Read more

Chasing Pulmonary Emboli

Chasing Pulmonary Emboli: Let’s Agree on One Big Thing Clinical practice guidelines can be great. It’s nice to have guidelines for the diagnosis, management, and long-term care objectives for basically every condition known to medicine. Clinical practice guidelines are supposed to be the foundation of 21st century evidence-based medicine. But clinicians frequently do not follow […]

Read more

When Will Malpractice Lawsuits Be Filed Against Armchair Doctors?

Blog Commentary Ferket and colleagues could have added to their long list a guideline from the Haute Autorité de Santé (High Authority for Health, the French agency for quality of care) which recommended in 2006 for the screening peripheral artery disease and its treatment with aspirin, despite evidence was lacking.(1,2) This French recommendation is surprising […]

Read more
American Journal of Medicine Editor Joseph Alpert

A Review of Clinical Guidelines with Some Thoughts about Their Utility and Appropriate Use

“Guidelines” has become one of the most common buzzwords for medical practitioners in the 21st century in our search to define and measure quality in health care. Physicians and other health care workers, administrators, bureaucrats, and politicians have all become involved in discussions concerning the attainment of quality in our medical care system. This is […]

Read more
American Journal of Medicine Editor Joseph Alpert

Guidelines Grind

Why Are We Ignoring Guideline Recommendations? In the current issue of The American Journal of Medicine, Lopes et al(1) report discouraging news. They examined a large cohort of patients taken from 3 large randomized double-blind clinical trials and asked the question: “Are patients in these trials who were in atrial fibrillation being treated with antithrombotic […]

Read more
UA-42320404-1